These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

684 related items for PubMed ID: 15866552

  • 1. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
    Petrakis IL, Poling J, Levinson C, Nich C, Carroll K, Rounsaville B, VA New England VISN I MIRECC Study Group.
    Biol Psychiatry; 2005 May 15; 57(10):1128-37. PubMed ID: 15866552
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Naltrexone and Disulfiram Treatment Response in Veterans With Alcohol Dependence and Co-Occurring Problem-Gambling Features.
    Grant JE, Potenza MN, Kraus SW, Petrakis IL.
    J Clin Psychiatry; 2017 May 15; 78(9):e1299-e1306. PubMed ID: 29345864
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid Axis I disorders.
    Ralevski E, Ball S, Nich C, Limoncelli D, Petrakis I.
    Am J Addict; 2007 May 15; 16(6):443-9. PubMed ID: 18058408
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparing treatments of alcoholism on craving and biochemical measures of alcohol consumptionst.
    Nava F, Premi S, Manzato E, Lucchini A.
    J Psychoactive Drugs; 2006 Sep 15; 38(3):211-7. PubMed ID: 17165363
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia.
    Petrakis IL, O'Malley S, Rounsaville B, Poling J, McHugh-Strong C, Krystal JH, VA Naltrexone Study Collaboration Group.
    Psychopharmacology (Berl); 2004 Mar 15; 172(3):291-7. PubMed ID: 14634716
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.
    Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B.
    Alcohol Alcohol; 2000 Mar 15; 35(6):587-93. PubMed ID: 11093966
    [Abstract] [Full Text] [Related]

  • 15. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF, Connor JP, Young RM, Tucker J, McPherson A.
    Alcohol Alcohol; 2006 Mar 15; 41(3):321-7. PubMed ID: 16467406
    [Abstract] [Full Text] [Related]

  • 16. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
    Baser O, Chalk M, Rawson R, Gastfriend DR.
    Am J Manag Care; 2011 Jun 15; 17 Suppl 8():S222-34. PubMed ID: 21761948
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence.
    De Sousa A, De Sousa A.
    Alcohol Alcohol; 2004 Jun 15; 39(6):528-31. PubMed ID: 15525790
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.